Second-line strategies after anti-TNF failure in chronically active, moderate-to-severe ulcerative colitis: a retrospective, multicentre cohort study
After first-line anti-TNF failure, switching to a non-anti-TNF agent is worth considering in moderate-to-severe UC.
Authors
- Zoltán Szepes (ORCID: https://orcid.org/0000-0002-9466-8719)
- Bernadett Farkas
- A Kagramanova (ORCID: https://orcid.org/0000-0002-3818-6205)
- Jakob Benedict Seidelin (ORCID: https://orcid.org/0000-0003-3230-7966)
- Mohamed Attauabi (ORCID: https://orcid.org/0000-0003-0323-7030)
- Luisa Bertin (ORCID: https://orcid.org/0009-0001-9816-4171)
- Milan Lukáš (ORCID: https://orcid.org/0000-0002-1463-3840)
- Simone Saibeni (ORCID: https://orcid.org/0000-0001-5677-2534)
- Fabiana Castiglione (ORCID: https://orcid.org/0000-0002-1099-442X)
- Pál Miheller (ORCID: https://orcid.org/0000-0002-7396-3145)
- Péter Bacsúr (ORCID: https://orcid.org/0000-0002-8534-0068)
- E. Yu. Chashkova (ORCID: https://orcid.org/0000-0002-7953-6523)
- Panu Wetwittayakhlang (ORCID: https://orcid.org/0000-0002-5962-4112)
- Željko Krznarić (ORCID: https://orcid.org/0000-0003-3758-4540)
- Mariann Borsos
- F Vilmos
- Edoardo Vincenzo Savarino (ORCID: https://orcid.org/0000-0002-3187-2894)
- Davide Giuseppe Ribaldone (ORCID: https://orcid.org/0000-0002-9421-3087)
- Nitsan Maharshak (ORCID: https://orcid.org/0000-0002-9324-0024)
- Jimmy K. Limdi (ORCID: https://orcid.org/0000-0002-1039-6251)
- Giorgos D. Michalopoulos (ORCID: https://orcid.org/0000-0002-7473-7262)
- Patrícia Sarlós (ORCID: https://orcid.org/0000-0002-5086-9455)
- Karishma Sethi-Arora
- Livio Bonacci (ORCID: https://orcid.org/0009-0007-6485-2631)
- Tamás F. Molnár (ORCID: https://orcid.org/0000-0002-9851-5832)
- Galia Berman
- Klaudia Farkas
- Ariella Bar-Gil Shitrit
- T Resál
- P. Lakatos (ORCID: https://orcid.org/0000-0002-7652-3671)
Institutions
- Semmelweis University (HU)
- Prince of Songkla University (TH)
- University of Padua (IT)
- University Hospital Centre Zagreb (HR)
- Tel Aviv University (IL)
- University of Szeged (HU)
- Tel Aviv Sourasky Medical Center (IL)
- McGill University Health Centre (CA)
- Gentofte Hospital (DK)
- Northern Health and Social Care Trust (GB)
- Moscow Clinical Scientific Center (RU)
- General Hospital of Athens G. Genimatas (GR)
- Iscare I.V.F (CZ)
- Irkutsk Regional Clinical Hospital (RU)
- Scientific Research Institute of Healthcare Organization and Medical Management (RU)
- Zagreb School of Business (HR)
- Irkutsk Scientific Center of Surgery and Traumatology (RU)
- Azienda Ospedale - Università Padova (IT)
- University of Turin (IT)
- University of Naples Federico II (IT)
- University of Pecs (HU)
Publication Details
- Journal
- Expert Opinion on Biological Therapy
- Published
- 2025-05-10
- DOI
- https://doi.org/10.1080/14712598.2025.2500962
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.82
Funders
- European Crohn's and Colitis Organisation
- United European Gastroenterology
- Szegedi Tudományegyetem
- Innovation Fund
- Nemzeti Kutatási, Fejlesztési és Innovaciós Alap
- National Research, Development and Innovation Office